NCT02106611|Completed
Loading search results
Sponsor study identifier
observational
133
1 country
1
Study Start
April 2014
Actual (reported)Primary Completion
February 6, 2026
Actual (reported)Study Completion
February 6, 2026
Actual (reported)This study will test whether cardiac MRI can improve early detection of Hodgkin lymphoma associated heart disease compared to a stress echocardiogram. By doing both stress echocardiography and cardiac MRI, we will compare the ability of the two tests to detect heart disease.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 6, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2014
Actual (reported)April 3, 2014
Actual (reported)April 8, 2014
Actual (reported)February 6, 2026
Actual (reported)February 6, 2026
Actual (reported)compare the prevalence of cardiac injury
detected by cardiac MRI to that detected by stress echocardiography among a broadly representative cohort of Hodgkin lymphoma survivors.
2 years
This is a prospective cross-sectional study of 200 HL survivors whose treatment included mediastinal RT at initial diagnosis or relapse, and are at least 5 years from last HL treatment.
HL treatment will be determined by review of available medical records as archived at MSKCC. Recorded variables will include: (1) RT - field, fractional and cumulative dose, and duration; (2) chemotherapy - regimen, planned interval, dose per cycle, and cumulative dosages. Patients will also be asked to complete the FACT-LYM questionnaire and the FACIT Fatigue questionnaire.
Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.
MSKCC
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Alison Moskowitz, MD
Memorial Sloan Kettering Cancer Center
133 participants (actual enrollment reported by the registry).
First Submitted
April 3, 2014
First Posted
April 8, 2014
Study Start
April 2014
Actual (reported)Comparison of Neuromuscular Blockade's Monitoring and Clinical Assessment During Cisatracurium Paralysis in Critically Ill Patients
Real-PD Trial: Development of Clinical Prognostic Models for Parkinson's Disease
PROspective Multicenter Imaging Study for Evaluation of Chest Pain
Both imaging tests will be performed within a 30 day interval, with the two modalities interpreted by dedicated study investigators blinded to the results of the other modality.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
February 6, 2026
Actual (reported)Study Completion
February 6, 2026
Actual (reported)Last Updated
February 11, 2026
Record last verified: 2026-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: